Mount Lucas Management’s Biocept, Inc. BIOC Stock Holding History

Mount Lucas Management’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2	Closed	-$31K	–	164
2017 Q1	$31K	Buy	+2	New	+$34K	0.01%	139

Other funds holding BIOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

GBA

Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Mount Lucas Management's BIOC Position: Q2 2017 in Review

Mount Lucas Management sold out of Biocept, Inc. (BIOC) in Q2 2017, closing a stake of 2 shares — an estimated $31K sold.

Mount Lucas Management first reported a position in BIOC in Q1 2017 and held it in 1 quarter. The position peaked at $31K in Q1 2017. 15 funds tracked by Wall St. Rank hold BIOC as of Q2 2017.

Mount Lucas Management reported no remaining Biocept, Inc. position as of Q2 2017 after selling out during the quarter.
Mount Lucas Management sold 2 Biocept, Inc. shares in Q2 2017, an estimated $31K.
Mount Lucas Management first reported a position in Biocept, Inc. in Q1 2017 and held it in 1 quarter.
Mount Lucas Management's Biocept, Inc. position peaked at $31K in Q1 2017.
15 funds tracked by Wall St. Rank held Biocept, Inc. as of Q2 2017.

Based on Mount Lucas Management's 13F filing for Q2 2017, filed 14 Aug 2017.